The introduction of a stricter approval process for prescribing an anti-seizure drug that can cause birth defects when taken during pregnancy has been effective at reducing the number of prescriptions issued for the drug, according to new research.
Continue Reading
News Source: medicalxpress.com
Leave a Reply